#merck
Latest news and interesting information about merck.
Jefferies Starts Merck KGaA at Hold
Jefferies starts Merck KGaA at Hold with a €129 price target, citing balanced valuation and limited upside.
Why is Merck stock surging today?
Merck stock surges 4.7% on positive lung cancer trial results, strong Q1 earnings, and EMA recommendation for Keytruda combination in bladder cancer.
Why is Summit Therapeutics stock sliding?
Summit Therapeutics stock drops 5.3% after Bernstein and H.C. Wainwright issue bearish ratings. Analyst concerns over trial failures drive sell-off.
Summit Therapeutics downgraded to neutral
H.C. Wainwright downgrades Summit Therapeutics to Neutral due to competitive pressure from Merck.
Exelixis CFO Senner Sells $1.75M in Stock
Exelixis CFO Christopher Senner sold $1.75 million worth of company stock. The company shows strong financial health.
Exelixis SVP Brenda Hefti sells $332,641 in stock
Exelixis SVP Brenda Hefti sells $332,641 in stock. Shares trade near 52-week high. Company valued at $12.25B. Details on Bond.az.
Merck SWOT Analysis: Stock Rises on Strong Pipeline
Merck SWOT analysis: strong pipeline, Keytruda transition, and growth outlook. Detailed stock performance and risks.
Merck Raises $6B in Bond Sale to Refinance Terns Deal
Merck & Co. raises $6 billion in investment-grade bond sale to refinance debt from Terns Pharmaceuticals acquisition.
...